CMPH 20-23 March 2006 Initial Marketing Authorisation Applications - European Medicines Agency

... The Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions on initial marketing authorisation applications for:-- Ganfort (bimatoprost/timolol), Allergan Pharmaceuticals Ireland. Ganfort is an eye-drop solution, intended for reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues... click link for more info. ...